These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 37634703)
1. No evidence of important difference in summary treatment effects between COVID-19 preprints and peer-reviewed publications: a meta-epidemiological study. Davidson M; Evrenoglou T; Graña C; Chaimani A; Boutron I J Clin Epidemiol; 2023 Oct; 162():90-97. PubMed ID: 37634703 [TBL] [Abstract][Full Text] [Related]
2. Comparison of effect estimates between preprints and peer-reviewed journal articles of COVID-19 trials. Davidson M; Evrenoglou T; Graña C; Chaimani A; Boutron I BMC Med Res Methodol; 2024 Jan; 24(1):9. PubMed ID: 38212714 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Preprint Postings of Randomized Clinical Trials on COVID-19 and Corresponding Published Journal Articles: A Systematic Review. Bai AD; Jiang Y; Nguyen DL; Lo CKL; Stefanova I; Guo K; Wang F; Zhang C; Sayeau K; Garg A; Loeb M JAMA Netw Open; 2023 Jan; 6(1):e2253301. PubMed ID: 36705921 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Clinical Study Results Reported in medRxiv Preprints vs Peer-reviewed Journal Articles. Janda G; Khetpal V; Shi X; Ross JS; Wallach JD JAMA Netw Open; 2022 Dec; 5(12):e2245847. PubMed ID: 36484989 [TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
7. Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis. Janiaud P; Axfors C; Schmitt AM; Gloy V; Ebrahimi F; Hepprich M; Smith ER; Haber NA; Khanna N; Moher D; Goodman SN; Ioannidis JPA; Hemkens LG JAMA; 2021 Mar; 325(12):1185-1195. PubMed ID: 33635310 [TBL] [Abstract][Full Text] [Related]
8. Changes in evidence for studies assessing interventions for COVID-19 reported in preprints: meta-research study. Oikonomidi T; Boutron I; Pierre O; Cabanac G; Ravaud P; BMC Med; 2020 Dec; 18(1):402. PubMed ID: 33334338 [TBL] [Abstract][Full Text] [Related]
9. Publication and Impact of Preprints Included in the First 100 Editions of the CDC COVID-19 Science Update: Content Analysis. Otridge J; Ogden CL; Bernstein KT; Knuth M; Fishman J; Brooks JT JMIR Public Health Surveill; 2022 Jul; 8(7):e35276. PubMed ID: 35544426 [TBL] [Abstract][Full Text] [Related]
10. Consistency of covid-19 trial preprints with published reports and impact for decision making: retrospective review. Zeraatkar D; Pitre T; Leung G; Cusano E; Agarwal A; Khalid F; Escamilla Z; Cooper MA; Ghadimi M; Wang Y; Verdugo-Paiva F; Rada G; Kum E; Qasim A; Bartoszko JJ; Siemieniuk RAC; Patel C; Guyatt G; Brignardello-Petersen R BMJ Med; 2022; 1(1):e000309. PubMed ID: 36936583 [TBL] [Abstract][Full Text] [Related]
11. Reliability of citations of medRxiv preprints in articles published on COVID-19 in the world leading medical journals. Gehanno JF; Grosjean J; Darmoni SJ; Rollin L PLoS One; 2022; 17(8):e0264661. PubMed ID: 35947594 [TBL] [Abstract][Full Text] [Related]
12. Pre2Pub-Tracking the Path From Preprint to Journal Article: Algorithm Development and Validation. Langnickel L; Podorskaja D; Fluck J J Med Internet Res; 2022 Apr; 24(4):e34072. PubMed ID: 35285808 [TBL] [Abstract][Full Text] [Related]
13. Robustness of evidence reported in preprints during peer review. Nelson L; Ye H; Schwenn A; Lee S; Arabi S; Hutchins BI Lancet Glob Health; 2022 Nov; 10(11):e1684-e1687. PubMed ID: 36240832 [TBL] [Abstract][Full Text] [Related]
14. Trial characteristics and treatment effect estimates in randomized controlled trials of Chinese herbal medicine: A meta-epidemiological study. Wang BH; Lin YL; Gao YY; Song JL; Qin L; Li LQ; Liu WQ; Zhong CCW; Jiang MY; Mao C; Yang XB; Chung VCH; Wu IXY J Integr Med; 2024 May; 22(3):223-234. PubMed ID: 38714484 [TBL] [Abstract][Full Text] [Related]
15. Characteristics of academic publications, preprints, and registered clinical trials on the COVID-19 pandemic. Gianola S; Jesus TS; Bargeri S; Castellini G PLoS One; 2020; 15(10):e0240123. PubMed ID: 33022014 [TBL] [Abstract][Full Text] [Related]
16. Enabling preprint discovery, evaluation, and analysis with Europe PMC. Levchenko M; Parkin M; McEntyre J; Harrison M PLoS One; 2024; 19(9):e0303005. PubMed ID: 39325770 [TBL] [Abstract][Full Text] [Related]
17. Completeness and consistency of primary outcome reporting in COVID-19 publications in the early pandemic phase: a descriptive study. Stoll M; Lindner S; Marquardt B; Salholz-Hillel M; DeVito NJ; Klemperer D; Lieb K BMC Med Res Methodol; 2023 Jul; 23(1):173. PubMed ID: 37516878 [TBL] [Abstract][Full Text] [Related]
19. Publishing in pandemic times: A bibliometric analysis of early medical publications on Kawasaki-like disease (MIS-C, PIMS-TS) related to SARS-CoV-2. Morand A; Urbina D; Giovannini-Chami L; Fabre A Arch Pediatr; 2021 Aug; 28(6):464-469. PubMed ID: 34140220 [TBL] [Abstract][Full Text] [Related]
20. Cross-sectional study of preprints and final journal publications from COVID-19 studies: discrepancies in results reporting and spin in interpretation. Bero L; Lawrence R; Leslie L; Chiu K; McDonald S; Page MJ; Grundy Q; Parker L; Boughton S; Kirkham JJ; Featherstone R BMJ Open; 2021 Jul; 11(7):e051821. PubMed ID: 34272226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]